Sign in Subscribe
Health care industry

Sorin Group Announces First Patient Enrollment in BITAC Study to Assess Slow Ventricular Tachycardias in Heart Failure Patients

Strategic Insights

— 1 min read

The BITAC study, led by Dr. Alexander Bauer at the University Hospital of Heidelberg, aims to assess the incidence of slow ventricular tachycardias (VTs) in heart failure patients implanted with CRT-D devices. The study will enroll over 400 patients across Europe and will provide physicians with better insight into the management of slow VTs for heart failure patients. Sorin Group's innovative technology, including the unique Brady Tachy Overlap (BTO) function, will be used to monitor and treat slow VTs in heart failure patients.

Key Takeaways:

  • The BITAC study aims to assess the incidence of slow VTs in heart failure patients implanted with CRT-D devices, with a focus on the clinical relevance of treating slow VTs during a 2-year follow-up period.
  • The study has enrolled its first patients, who were implanted with Sorin Group's Ovatio CRM device, which includes the BTO function that allows the setting of low-rate detection zones for slow VTs.
  • The study will provide physicians with better insight into the management of slow VTs for heart failure patients, which is a priority due to the high prevalence of slow VTs in this population.
  • Patients included in the study have advanced heart failure and are at increased risk of sudden cardiac death (SCD), which affects over 10 million Europeans.
  • The study will enroll over 400 patients across Europe, with enrollment anticipated to be completed by end 2007.

Statistics:

  • 10 million Europeans are affected by heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs.
  • Patients with heart failure are up to 9 times more likely to suffer SCD than the general population.
  • Sorin Group has more than 4,700 employees working at facilities in over 80 countries to serve over 5,000 public and private treatment centers.
  • The BITAC study will use Sorin Group's innovative technology, including the unique BTO function, to monitor and treat slow VTs in heart failure patients.

Sources:

  • Internal sub-analysis (375 patients) of the IDEF08 Slow VT study (Sadoul et al., 2005)
  • The EuroHeart Failure Survey Programme (Cleland et al., 2003)
  • Heart Disease and Stroke Statistics (American Heart Association, 2005 Update)

Read more